Spero Therapeutics (SPRO)
1.17
-0.05 (4.10%)
Upcoming Events
Latest Headlines
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
October 15, 2026 4:05 PM - Globe NewsWire
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026 4:05 PM - Globe NewsWire
Spero Therapeutics (SPRO) PT Raised to $6 at H.C. Wainwright
September 14, 2026 6:56 AM - StreetInsider
Form EFFECT Spero Therapeutics, Inc.
September 11, 2026 6:04 AM - SEC Filing
Form 8-K Spero Therapeutics, Inc. For: Aug 28
August 28, 2026 5:26 PM - SEC Filing
Form S-3 Spero Therapeutics, Inc.
August 28, 2026 5:04 PM - SEC Filing
SmartPros Ltd. (SPRO) Tops Q2 EPS by 1c
August 12, 2026 4:41 PM - StreetInsider
Form 8-K Spero Therapeutics, Inc. For: Aug 12
August 12, 2026 4:10 PM - SEC Filing
Form 10-Q Spero Therapeutics, Inc. For: Jun 30
August 12, 2026 4:03 PM - SEC Filing
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
August 12, 2026 4:01 PM - Globe NewsWire
Form 3 Spero Therapeutics, Inc. For: Aug 03 Filed by: Zack Debra
August 12, 2026 11:03 AM - SEC Filing
Form 4 Spero Therapeutics, Inc. For: Aug 03 Filed by: Zack Debra
August 12, 2026 11:03 AM - SEC Filing
Form 4 Spero Therapeutics, Inc. For: Aug 03 Filed by: Zack Debra
August 6, 2026 6:49 PM - SEC Filing
Form 3 Spero Therapeutics, Inc. For: Aug 03 Filed by: Zack Debra
August 6, 2026 6:42 PM - SEC Filing
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 5, 2026 4:05 PM - StreetInsider
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
August 4, 2026 4:01 PM - Globe NewsWire
Spero Therapeutics names new chief medical officer
July 27, 2026 8:00 AM - StreetInsider
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
July 27, 2026 8:00 AM - Globe NewsWire
Full Article List
